Is age-related macular degeneration associated with serum lipoprotein and lipoparticle levels? (Q44205291)

30 November 2017

Is age-related macular degeneration associated with serum lipoprotein and lipoparticle levels? (English)

1 reference

30 November 2017

1 reference

1 reference

Jean-Hervé Abalain

1

1 reference

30 November 2017

Jean-Luc Carre

2

1 reference

30 November 2017

Dominique Leglise

3

1 reference

30 November 2017

Anne Robinet

4

1 reference

30 November 2017

Françoise Legall

5

1 reference

30 November 2017

Ahmed Meskar

6

1 reference

30 November 2017

Hervé-Henri Floch

7

1 reference

30 November 2017

Joseph Colin

8

1 reference

30 November 2017

1 December 2002

1 reference

30 November 2017

1 reference

30 November 2017

326

1 reference

30 November 2017

1-2

1 reference

30 November 2017

97-104

1 reference

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Senile macular degeneration: review of epidemiologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

A prospective study of cigarette smoking and age-related macular degeneration in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Associations of antioxidant enzymes with cataract and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Familial aggregation of age-related maculopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Genetic association of apolipoprotein E with age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Aging changes in Bruch's membrane. A histochemical and morphologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Clinicopathologic correlation of occult choroidal neovascularization in age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Risk factors in age-related maculopathy complicated by choroidal neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Senile macular degeneration and alteration of the metabolism of the lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Serum levels of antioxidants and age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

The determination of lipoprotein Lp(a) by rate and endpoint nephelometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Genetic associations with human longevity at the APOE and ACE loci.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900288-7

10.1016/S0009-8981(02)00288-7

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference